Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-04-23 03:47 CEST (UTC+2h)
 

EMA Product Specific GL [Regulatives / Guidelines]

posted by mmw - India, 2017-07-14 14:50  - Posting: # 17548
Views: 2,843

Dear all,

EMA adopted a new batch of product specific guidances. Published on 10/07/2017:

Crizotinib
Elvitegravir / cobicistat / emtricitabine / te­no­fovir disoproxil
Elvitegravir
Emtricitabine, rilpivirine, tenofovir, disopro­xil
Vortioxetine

Thanks

MMW

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
18,202 posts in 3,870 threads, 1,153 registered users;
33 users online (0 registered, 33 guests).

Not to be absolutely certain is, I think,
one of the essential things in rationality.    Bertrand Russell

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed